XML 64 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-In Capital
Accumulated deficit
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2018   22,471,776      
Beginning balance at Dec. 31, 2018 $ (5,418) $ 3 $ 279,539 $ (280,403) $ (4,557)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock under Employee Stock Purchase Plan (in shares)   11,943      
Issuance of common stock under Employee Stock Purchase Plan 20   20    
Issuance of common stock upon exercise of options (in shares)   115,600      
Issuance of common stock upon exercise of options 145   145    
Stock‑based compensation expense 1,180   1,180    
Foreign currency translation adjustment 22       22
Net loss (12,074)     (12,074)  
Issuance of common stock, net of issuance costs (in shares)   22,188,706      
Issuance of common stock, net of issuance costs 30,942 $ 2 30,940    
Unrealized gain on securities 2       2
Ending balance (in shares) at Mar. 31, 2019   44,788,025      
Ending balance at Mar. 31, 2019 $ 14,819 $ 5 311,824 (292,477) (4,533)
Beginning balance (in shares) at Dec. 31, 2019 86,325,547 86,325,547      
Beginning balance at Dec. 31, 2019 $ 8,397 $ 9 348,664 (335,753) (4,523)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock under Employee Stock Purchase Plan (in shares)   78,583      
Issuance of common stock under Employee Stock Purchase Plan 114   114    
Issuance of common stock upon exercise of options (in shares)   5,128      
Issuance of common stock upon exercise of options 3   3    
Issuance of vested restricted stock units (in shares)   10,937      
Issuance of common stock through at-the-market offering, net (in shares)   598,977      
Issuance of common stock through at-the-market offering, net 1,141   1,141    
Other financing fees (147)   (147)    
Stock‑based compensation expense 1,409   1,409    
Foreign currency translation adjustment (60)       (60)
Net loss (19,620)     (19,620)  
Unrealized gain on securities $ 0        
Ending balance (in shares) at Mar. 31, 2020 87,019,172 87,019,172      
Ending balance at Mar. 31, 2020 $ (8,763) $ 9 $ 351,184 $ (355,373) $ (4,583)